GlassScriptPhysician profile
Leonardo A Orejarena
NPI 1932153376
$8,492.10
in general payments reported to CMS, 2019-2025
26 companies · $1,193 in 2025
The $1,193 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,180 · 2020: $197 · 2021: $602 · 2022: $2,602 · 2023: $870 · 2024: $1,848 · 2025: $1,193.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,244 · Travel and Lodging: $667.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,243.78 |
| Travel and Lodging | $666.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,907.56 | 2019-2025 | Aveir, Cardiomems, Jot Dx |
| Biotronik INC. | $992.93 | 2019-2025 | Acticor 7 Vr-T Dx |
| Shockwave Medical, INC | $588.93 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $465.55 | 2020-2025 | Impella |
| Boston Scientific Corporation | $438.53 | 2019-2025 | Rotapro |
| Medtronic, INC. | $409.40 | 2021-2024 | Micra |
| Novartis Pharmaceuticals Corporation | $292.71 | 2020-2023 | |
| Kestra Medical Technology Services, INC. | $199.85 | 2023-2025 | Assure Wcd |
| Inspire Medical Systems, INC. | $178.13 | 2023-2025 | Inspire |
| Merck Sharp & Dohme LLC | $152.23 | 2023-2024 | Verquvo |
| Edwards Lifesciences Corporation | $143.83 | 2025 | |
| Irhythm Technologies, INC. | $128.38 | 2024 | Zio Xt Patch, Zio Monitor |
| E.R. Squibb & Sons, L.L.C. | $97.44 | 2024-2025 | Camzyos |
| Philips North America LLC | $85.91 | 2021 | |
| Siemens Medical Solutions USA, INC. | $76.44 | 2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $54.69 | 2020 | |
| Impulse Dynamics (USA) INC. | $52.25 | 2022 | |
| Medtronic Vascular, INC. | $51.27 | 2019-2020 | |
| Davol INC. | $42.98 | 2025 | Arista |
| Novo Nordisk INC | $31.08 | 2024-2025 | Wegovy, Ozempic |
| Contego Medical, INC | $28.85 | 2025 | |
| Scpharmaceuticals INC. | $20.02 | 2025 | |
| Amgen INC. | $14.43 | 2023 | Repatha |
| Janssen Pharmaceuticals, INC | $13.61 | 2019 | |
| Cardiovascular Systems INC. | $13.03 | 2021 | |
| Sanofi-Aventis U.S. LLC | $12.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leonardo Orejarena listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.